Are there any UMGCC research studies open to patients with lung cancer?
UMGCC offers access to some of the most important new drugs in development for the treatment of lung cancer and other thoracic cancers. These trials test a variety of approaches, including the evaluation of new drugs for lung cancer as well as potentially better ways of using old drugs. These new drugs contain different mechanisms of action than previously used anti-cancer drugs. A clinical study is now underway to evaluate treatment with a new drug called Velcade, combined with standard chemotherapy and radiation, for patients with locally advanced non-small cell lung cancer. UMGCC is the first institution to test this new combination therapy. Other clinical trials in lung cancer include new drugs for initial therapy as well as second and subsequent therapies. Return to the Thoracic Oncology treatment program. This page was last updated on: December 5, 2006.
